MCET Discussion Topics 08/25/2014 17:22:44 $MCET
Recently Merck tendered an offer of more than $3 billion to acquire Idenix Pharmaceuticals Inc . Idenix is a 'biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases'.
According to their 10-K filing, Idenix only had revenue of $469,000 for all of CY 2013 (see link below for filing), no revenue for Q1 or Q2 of 2014 (according to google finance), and has been bleeding money for several years.
Yet Merck has tendered an offer valued at more than $3 billion, because of the patents they own and the research they have conducted.
So here's an intriguing piece of info... Merck only derived about 3% of its revenue in Q1 2013 from Cancer related drugs. When an industry giant is weak in a particular area, they often use acquisitions to strengthen their weakest areas.
It would seem plausible that a company like Merck, who has already demonstrated their willingness and desire to acquire smaller companies, might eventually be willing to buy a company like MultiCell (for their research performed and patents held). And based upon the $3 billion Merck will be paying for Idenix (with little or no recent revenue), any possible offer could be rich indeed. Could you imagine how an OTC stock would react if Merck expressed some interest in owning them?
As always, simply my opinion.
Merck Completes Tender Offer to Acquire Idenix
http://www.marketwatch.com/story/merck-comple...2014-08-05
Why Did Merck Pay Such A Huge Premium For Idenix?
http://www.forbes.com/sites/greatspeculations...or-idenix/
Link to Idenix Pharmaceuticals Inc 2013 10-K:
http://www.sec.gov/Archives/edgar/data/109364...-index.htm
MCET
Tomorrow another 50% up
MCET Stock Message Board http://investorshangout.com/Multicell-Techs-Inc-MCET-64069/
ok, the same to u!
lol!
Actually, it is not directly assigned to MCET, I'd take a look.
Missed Simple Simon today. We can now say his bashing ammunition has been narrowed by at least 2 things.
1. MCET does absolutely nothing
2. No patents in MCET's name. (This one is)
Looks like shorting happened on MCET. Short covering tomorrow
* * $MCET Video Chart 8-25-14 * *
Link to Video - click here to watch the technical chart video
realistically this attempts to go touch .0020 - .0022 the high from the last run, will likely fail there....
700m vol says this is more then one day play.
Eow high.....guesses? Nice base here
IP (intellectual property) on the production of wine by the glass was offered up for an investment on Shark Tank, and I recall one of the sharks offering several million dollars (with an intent to license out the patent rights).
So how much might one of the big pharma boys (such as Merck, Pfizer, etc) be willing to pay for the patent(s) which not only effectively target cancer cells, but also provide the patient with some sort of preventive shield against the formation of new tumors? I would think the starting price would have to be at least in the tens of millions of dollars, if not more.
Here's an exerpt from today's PR:
'In mouse cancer models, the combination of MCT-465, a dsRNA therapeutic, and MCT-475, an IgP therapeutic, not only induced the animal's immune system to eradicate the engrafted tumor, but upon rechallenge with tumor cells, no new tumors developed indicating the animal had developed protective anti-tumoral immunity. Tumor rejection and protection against similar and new tumor variants was found to also be associated with specific, overall expansion of cytokine producing cells. This finding indicates a broadening of the repertoire of anti-tumor immune cells and the development of immune memory in the animal'
As always, simply my opinion.
MCET
We must have both missed it, and he prob missed the buying opp he wanted at 9... Scare tactics and pennies are so original
MASSIVE VOLUME!!!! 751 MILLIONS SHARES TRADE. WOW!)))
Kracken3 - 50M @ 9 - Did I miss it?
Can't short MCET at the retail level, believe me, today would have been a great day to do so.
Shorts how does the sting feel today~
Golf clap for you Geb!! Never said it wouldn't. LOL
Nope not trying to save anyone. But not foolish enough to accumulate here either. I would expect anyone who has a position to defend it or why have one. JMHO. Never wish ill will for anyone and glad you cught the move. Got the alert, read the news end of story. GLTU
THOSE WHO HAVE FOLLOWED MCET FOR SOME TIME KNOW THIS AS A MUTI-DAY RUNNER,PATENTS ISSUED FOR CANCER KILLING PROPERTIES USING THE IMMUME SYSTEM READING LIKE A VACCINE IS NOT (FLUFF) NEWS----IN THE COMING DAYS MCET WILL TRADE UPWARD SETTING ITS NEWLY VALUED SHARE PRICE, MY VIEW OF MCET
Recently Merck tendered an offer of more than $3 billion to acquire Idenix Pharmaceuticals Inc . Idenix is a 'biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases'.
According to their 10-K filing, Idenix only had revenue of $469,000 for all of CY 2013 (see link below for filing), no revenue for Q1 or Q2 of 2014 (according to google finance), and has been bleeding money for several years.
Yet Merck has tendered an offer valued at more than $3 billion, because of the patents they own and the research they have conducted.
So here's an intriguing piece of info... Merck only derived about 3% of its revenue in Q1 2013 from Cancer related drugs. When an industry giant is weak in a particular area, they often use acquisitions to strengthen their weakest areas.
It would seem plausible that a company like Merck, who has already demonstrated their willingness and desire to acquire smaller companies, might eventually be willing to buy a company like MultiCell (for their research performed and patents held). And based upon the $3 billion Merck will be paying for Idenix (with little or no recent revenue), any possible offer could be rich indeed. Could you imagine how an OTC stock would react if Merck expressed some interest in owning them?
As always, simply my opinion.
Merck Completes Tender Offer to Acquire Idenix
http://www.marketwatch.com/story/merck-comple...2014-08-05
Why Did Merck Pay Such A Huge Premium For Idenix?
http://www.forbes.com/sites/greatspeculations...or-idenix/
Link to Idenix Pharmaceuticals Inc 2013 10-K:
http://www.sec.gov/Archives/edgar/data/109364...-index.htm
MCET
Tomorrow another 50% up
MCET Stock Message Board http://investorshangout.com/Multicell-Techs-Inc-MCET-64069/
ok, the same to u!
lol!
Actually, it is not directly assigned to MCET, I'd take a look.
Missed Simple Simon today. We can now say his bashing ammunition has been narrowed by at least 2 things.
1. MCET does absolutely nothing
2. No patents in MCET's name. (This one is)
Looks like shorting happened on MCET. Short covering tomorrow
* * $MCET Video Chart 8-25-14 * *
Link to Video - click here to watch the technical chart video
realistically this attempts to go touch .0020 - .0022 the high from the last run, will likely fail there....
700m vol says this is more then one day play.
Eow high.....guesses? Nice base here
IP (intellectual property) on the production of wine by the glass was offered up for an investment on Shark Tank, and I recall one of the sharks offering several million dollars (with an intent to license out the patent rights).
So how much might one of the big pharma boys (such as Merck, Pfizer, etc) be willing to pay for the patent(s) which not only effectively target cancer cells, but also provide the patient with some sort of preventive shield against the formation of new tumors? I would think the starting price would have to be at least in the tens of millions of dollars, if not more.
Here's an exerpt from today's PR:
'In mouse cancer models, the combination of MCT-465, a dsRNA therapeutic, and MCT-475, an IgP therapeutic, not only induced the animal's immune system to eradicate the engrafted tumor, but upon rechallenge with tumor cells, no new tumors developed indicating the animal had developed protective anti-tumoral immunity. Tumor rejection and protection against similar and new tumor variants was found to also be associated with specific, overall expansion of cytokine producing cells. This finding indicates a broadening of the repertoire of anti-tumor immune cells and the development of immune memory in the animal'
As always, simply my opinion.
MCET
We must have both missed it, and he prob missed the buying opp he wanted at 9... Scare tactics and pennies are so original
MASSIVE VOLUME!!!! 751 MILLIONS SHARES TRADE. WOW!)))
Kracken3 - 50M @ 9 - Did I miss it?
Can't short MCET at the retail level, believe me, today would have been a great day to do so.
Shorts how does the sting feel today~
Golf clap for you Geb!! Never said it wouldn't. LOL
Nope not trying to save anyone. But not foolish enough to accumulate here either. I would expect anyone who has a position to defend it or why have one. JMHO. Never wish ill will for anyone and glad you cught the move. Got the alert, read the news end of story. GLTU
THOSE WHO HAVE FOLLOWED MCET FOR SOME TIME KNOW THIS AS A MUTI-DAY RUNNER,PATENTS ISSUED FOR CANCER KILLING PROPERTIES USING THE IMMUME SYSTEM READING LIKE A VACCINE IS NOT (FLUFF) NEWS----IN THE COMING DAYS MCET WILL TRADE UPWARD SETTING ITS NEWLY VALUED SHARE PRICE, MY VIEW OF MCET
